Option Care Health, Inc.
OPCH
株式のランク
#3626
Option Care Health, Inc. delivers infusion services to patients in their homes... Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
株価
$31.32
最終同期: 2026-10-20
時価総額
$4.69B
変化（1日）
0.34%
変化（1年）
11.01%
国
US
取引 Option Care Health, Inc. (OPCH)
カテゴリー
Healthcare
Option Care Health, Inc.（OPCH）の収益
Jun 2026 時点の収益 TTM: $5.69B
Option Care Health, Inc. の最新の財務報告によると、現在の収益 (TTM) は $5.69B です。2023 年には $4.30B の収益があり、これは 2022 年の $3.94B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Option Care Health, Inc. の収益履歴（2000 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $5.69B | 13.91% |
| 2024 | $5.00B | 16.17% |
| 2023 | $4.30B | 9.06% |
| 2022 | $3.94B | 14.72% |
| 2021 | $3.44B | 13.39% |
| 2020 | $3.03B | 31.26% |
| 2019 | $2.31B | 19.11% |
| 2018 | $1.94B | 137.37% |
| 2017 | $817.19M | -12.66% |
| 2016 | $935.59M | -4.75% |
| 2015 | $982.22M | 6.46% |
| 2014 | $922.65M | 32.48% |
| 2013 | $696.47M | 17.36% |
| 2012 | $593.45M | 7.02% |
| 2011 | $554.51M | 28.74% |
| 2010 | $430.71M | -67.60% |
| 2009 | $1.33B | -5.16% |
| 2008 | $1.40B | 17.05% |
| 2007 | $1.20B | 3.98% |
| 2006 | $1.15B | 7.37% |
| 2005 | $1.07B | 70.16% |
| 2004 | $630.52M | 7.09% |
| 2003 | $588.77M | 2.11% |
| 2002 | $576.60M | 26.27% |
| 2001 | $456.65M | 35.03% |
| 2000 | $338.17M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $78.01B | 1,270.21% |
US
|
|
| - | - |
DE
|
|
| $21.81B | 283.10% |
US
|
|
| $3.89B | -31.59% |
SA
|
|
| $11.08B | 94.69% |
BR
|
